Haishun New Materials released its 2026 interim report. Total operating revenue was 667 million yuan, and net profit attributable to the parent company was a loss of 15.85 million yuan, swinging from profit to loss year-on-year, a decrease of 42.96 million yuan from the same period last year, a decline of 158.43%. Net cash inflow from operating activities was 14.23 million yuan. The company's asset-liability ratio was 45.64%, gross margin was 20.73%, return on equity was negative 1.10%, and diluted earnings per share was negative 0.06 yuan. The number of shareholders was 10,200, and the top ten shareholders held 56.13% of the shares.
Shanghai Haishun New Pharmaceutical Packaging Co LtdNet loss of 15.85 million yuan, swinging from profit to loss year-on-year.
